A leading pharmaceutical company with cutting-edge capabilities in drug development and a history of successful academic collaborations wishes to identify infectious disease therapeutics and vaccines in European institutes, targeting Hepatitis B and Hepatitis D virus infection.
Jul
19
Comments are closed.